Unknown

Dataset Information

0

Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience.


ABSTRACT:

Introduction

The SARS-CoV-2 pandemic presented healthcare providers with an extreme challenge to provide cancer services. The impact upon the diagnostic and treatment capacity to treat pancreatic cancer is unclear. This study aimed to identify national variation in treatment pathways during the pandemic.

Methods

A survey was distributed to all United Kingdom pancreatic specialist centres, to assess diagnostic, therapeutic and interventional services availability, and alterations in treatment pathways. A repeating methodology enabled assessment over time as the pandemic evolved.

Results

Responses were received from all 29 centres. Over the first six weeks of the pandemic, less than a quarter of centres had normal availability of diagnostic pathways and a fifth of centres had no capacity whatsoever to undertake surgery. As the pandemic progressed services have gradually improved though most centres remain constrained to some degree. One third of centres changed their standard resectable pathway from surgery-first to neoadjuvant chemotherapy. Elderly patients, and those with COPD were less likely to be offered treatment during the pandemic.

Conclusion

The COVID-19 pandemic has affected the capacity of the NHS to provide diagnostic and staging investigations for pancreatic cancer. The impact of revised treatment pathways has yet to be realised.

SUBMITTER: McKay SC 

PROVIDER: S-EPMC7973054 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience.

McKay Siobhan C SC   Pathak Samir S   Wilkin Richard J W RJW   Kamarajah Sivesh K SK   Wigmore Stephen J SJ   Rees Jonathan J   Dunne Declan F J DFJ   Garcea Giuseppe G   Ahmad Jawad J   de Liguori Carino Nicola N   Sultana Asma A   Silva Mike M   Lykoudis Pavlos P   Nasralla David D   Milburn James J   Shah Nehal N   Kocher Hemant M HM   Bhogal Ricky R   Baron Ryan D RD   Navarro Alex A   Halle-Smith James J   Al-Sarireh Bilal B   Sen Gourab G   Jamieson Nigel B NB   Briggs Christopher C   Stell David D   Aroori Somaiah S   Bowles Matthew M   Kanwar Aditya A   Harper Simon S   Menon Krishna K   Prachalias Andreas A   Srinivasan Parthi P   Frampton Adam E AE   Jones Claire C   Arshad Ali A   Tait Iain I   Spalding Duncan D   Young Alastair L AL   Durkin Damien D   Ghods-Ghorbani Manijeh M   Sutcliffe Robert P RP   Roberts Keith J KJ  

HPB : the official journal of the International Hepato Pancreato Biliary Association 20210319 11


<h4>Introduction</h4>The SARS-CoV-2 pandemic presented healthcare providers with an extreme challenge to provide cancer services. The impact upon the diagnostic and treatment capacity to treat pancreatic cancer is unclear. This study aimed to identify national variation in treatment pathways during the pandemic.<h4>Methods</h4>A survey was distributed to all United Kingdom pancreatic specialist centres, to assess diagnostic, therapeutic and interventional services availability, and alterations i  ...[more]

Similar Datasets

| S-EPMC9213026 | biostudies-literature
| S-EPMC8363500 | biostudies-literature
| S-EPMC8652804 | biostudies-literature
| S-EPMC8247764 | biostudies-literature
| S-EPMC9384604 | biostudies-literature
| S-EPMC11346986 | biostudies-literature
| S-EPMC9296900 | biostudies-literature
| S-EPMC11466367 | biostudies-literature
| S-EPMC8693687 | biostudies-literature
| S-EPMC10202862 | biostudies-literature